ATAŞ, Ü. Et Al. 2022. Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.6 , 1474-1477.

ATAŞ, Ü., ERSOY, M., ILTAR, U., YÜCEL, O. K., TÜRKOĞLU ŞEN, E. B., & SALİM, O., (2022). Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.6, 1474-1477.

ATAŞ, ÜNAL Et Al. "Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.6, 1474-1477, 2022

ATAŞ, ÜNAL Et Al. "Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.6, pp.1474-1477, 2022

ATAŞ, Ü. Et Al. (2022) . "Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.6, pp.1474-1477.

@article{article, author={ÜNAL ATAŞ Et Al. }, title={Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2022, pages={1474-1477} }